Revised forecast
Fiscal year ending May 2026 · Full yearPrevious forecast published 14 July 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Revenue has been revised downward because temporary revenue contributions from sales of large medical equipment and other products by the C&Br service, the start of new transactions involving the purchase of medical and long-term care reimbursement receivables by the F&I service, and other factors were lower than expected, as were certain revenue items in the HR&OS service. Meanwhile, profit has been revised upward because consulting projects in the C&Br service exceeded expectations, the gross profit margin increased due to changes in the revenue mix, and selling, general and administrative expenses, particularly personnel expenses, were lower than expected.
| Item | Details |
|---|---|
| Net Sales | ¥1,703 million → ¥1,620 million（-4.9%） |
| Operating profit | ¥200 million → ¥270 million（+35.0%） |
| Ordinary income | ¥229 million → ¥310 million（+35.4%） |
| Profit attributable to owners of the parent | ¥151 million → ¥221 million（+46.4%） |
| Net income per share | 66.58 yen and sen → 96.79 yen and sen |
| Fiscal Period Covered | Fiscal year ending May 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 July 2025 |
| Previous-period results | Consolidated revenue of ¥1,502 million, consolidated operating income of ¥299 million, consolidated ordinary income of ¥300 million, net income attributable to owners of the parent of ¥220 million, and consolidated earnings per share of ¥98.85 |
| Reason for the revision | Revenue has been revised downward because temporary revenue contributions from sales of large medical equipment and other products by the C&Br service, the start of new transactions involving the purchase of medical and long-term care reimbursement receivables by the F&I service, and other factors were lower than expected, as were certain revenue items in the HR&OS service. Meanwhile, profit has been revised upward because consulting projects in the C&Br service exceeded expectations, the gross profit margin increased due to changes in the revenue mix, and selling, general and administrative expenses, particularly personnel expenses, were lower than expected. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.On the revenue side, temporary revenue contributions from sales of large medical equipment and the start of new factoring transactions were lower than expected, as were certain revenue items in the HR&OS service. On the profit side, consulting projects in the C&Br service exceeded expectations, and the gross profit margin increased due to changes in the revenue mix. In addition, selling, general and administrative expenses, particularly personnel expenses, were lower than expected.